Developmental Funds: CCSG Developmental Funds are critical for realizing the Research Strategic Plan (RSP). These investments support RSP elements emphasizing integrative science, innovation, and collaboration. In the previous renewal, MCC requested and was recommended to receive $400,000 per year in Developmental Funds for pilot projects and shared resources. However, after administrative reductions only $75,000 in CCSG developmental funding was available over the five-year period. These funds were leveraged with significant institutional funds to support pilot projects, which was ultimately the only category for which CCSG Developmental Funds were used. This CCSG investment returned more than $20 million in subsequent peer-reviewed funding and 54 publications. Future plans are to support collaborative pilot projects and invest in a novel mechanism to foster innovation in MCC cores over the next project period. MCC requests $190,000 for Developmental Funds to: 1) Foster innovative science through the support of collaborative pilot projects; and 2) Facilitate and Encourage Core Innovation. MCC will continue to recruit new faculty, allocate discretionary ?pre- pilot? funds for Program Leaders, and provide bridge funding for members; however this will be institutional support, and no CCSG funding is requested in these categories at this time. Staff Investigators: MCC's Centers of Excellence (CoE) build and foster transdisciplinary collaborations across all Research Programs based on areas of institutional strength that align with the needs of the catchment area. Staff Investigators lead each CoE, with the expectation that they bring together members from across all Research Programs to enhance discovery and translation through interdisciplinary and transdisciplinary team science. MCC has four CoEs, each led by a Staff Investigator, who reports directly to the Associate Center Director (ACD) of Translational Science. The four Staff Investigators, all of whom are accomplished, senior scientists, are: 1) Kieran Smalley, PhD, who leads the Melanoma CoE; 2) Eric Haura, MD, who leads the Lung Cancer CoE; 3) Anna Giuliano, PhD, who leads the Center for Infection Research in Cancer; and 4) Robert Gillies, PhD, who leads the Center for Imaging and Technology. MCC requests Staff Investigator support of 1.20 calendar months (10%) for the CoE Directors, partially supported by the CCSG ($44,725).

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA076292-20
Application #
9419791
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2018-02-01
Budget End
2019-01-31
Support Year
20
Fiscal Year
2018
Total Cost
Indirect Cost
Name
H. Lee Moffitt Cancer Center & Research Institute
Department
Type
DUNS #
139301956
City
Tampa
State
FL
Country
United States
Zip Code
33612
Tauro, Marilena; Shay, Gemma; Sansil, Samer S et al. (2017) Bone-Seeking Matrix Metalloproteinase-2 Inhibitors Prevent Bone Metastatic Breast Cancer Growth. Mol Cancer Ther 16:494-505
Davis, Stacy N; Christy, Shannon M; Chavarria, Enmanuel A et al. (2017) A randomized controlled trial of a multicomponent, targeted, low-literacy educational intervention compared with a nontargeted intervention to boost colorectal cancer screening with fecal immunochemical testing in community clinics. Cancer 123:1390-1400
Song, Jinming; Hussaini, Mohammad; Zhang, Hailing et al. (2017) Comparison of the Mutational Profiles of Primary Myelofibrosis, Polycythemia Vera, and Essential Thrombocytosis. Am J Clin Pathol 147:444-452
Strom, Tobin; Harrison, Louis B; Giuliano, Anna R et al. (2017) Tumour radiosensitivity is associated with immune activation in solid tumours. Eur J Cancer 84:304-314
Heit, Claire; Marshall, Stephanie; Singh, Surrendra et al. (2017) Catalase deletion promotes prediabetic phenotype in mice. Free Radic Biol Med 103:48-56
Eksioglu, E A; Chen, X; Heider, K-H et al. (2017) Novel therapeutic approach to improve hematopoiesis in low risk MDS by targeting MDSCs with the Fc-engineered CD33 antibody BI 836858. Leukemia 31:2172-2180
Kamath, Vidya P; Torres-Roca, Javier F; Eschrich, Steven A (2017) Integrating Biological Covariates into Gene Expression-Based Predictors of Radiation Sensitivity. Int J Genomics 2017:6576840
Liu, Ying; Balagurunathan, Yoganand; Atwater, Thomas et al. (2017) Radiological Image Traits Predictive of Cancer Status in Pulmonary Nodules. Clin Cancer Res 23:1442-1449
Chen, Yi; Fisher, Kate J; Lloyd, Mark et al. (2017) Multiplexed Liquid Chromatography-Multiple Reaction Monitoring Mass Spectrometry Quantification of Cancer Signaling Proteins. Methods Mol Biol 1647:19-45
Extermann, Martine; Leeuwenburgh, Christiaan; Samiian, Laila et al. (2017) Impact of chemotherapy on medium-term physical function and activity of older breast cancer survivors, and associated biomarkers. J Geriatr Oncol 8:69-75

Showing the most recent 10 out of 1137 publications